Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

TORC1 inhibition enhances immune function and reduces infections in the elderly

Open access

Published version of a preprint

Abstract

Treating elderly subjects with two low-dose mTOR inhibitors that selectively block TORC1 led to a decrease in infection rates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaq1564

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 496

Metadata

Authors
Mannick, J. B., Morris, M., Hockey, H.-U. P., Roma, G., Beibel, M., Kulmatycki, K., Watkins, M., Shavlakadze, T., Zhou, W., Quinn, D., Glass, D. J., & Klickstein, L. B.
Affiliations
  • Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Biometrics Matters Limited, Hamilton 3216, New Zealand.
  • Novartis (Switzerland) (CH)
  • P3 Research, Newtown, Wellington 6242, New Zealand.
Corresponding author
Mannick, Joan B.
Venue
Science Translational Medicine
Published
2018-07-11
Volume
10
Issue
449
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2844364183
Cited by
496
References
24
Citations by year
2026: 51 · 2025: 63 · 2024: 58 · 2023: 55 · 2022: 63 · 2021: 70 · 2020: 69 · 2019: 51 · 2018: 15
FWCI
18.23
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
Funders
Novartis
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
TORC1 inhibition, mTOR signaling, aging, immune function, infections in the elderly, antiviral gene expression, immunosenescence
MeSH terms
Everolimus, Mechanistic Target of Rapamycin Complex 1, Aged, Antibodies, Viral, Communicable Diseases, Dose-Response Relationship, Drug, Humans, Imidazoles, Immunity, Influenza, Human, Quinolines, Vaccination, Up-Regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TORC1 inhibition enhances immune function and reduces infections in the elderly. https://app.cochat.ai/papers/10.1126/scitranslmed.aaq1564
The paper
Mannick, J. B., Morris, M., Hockey, H.-U. P., Roma, G., Beibel, M., Kulmatycki, K., Watkins, M., Shavlakadze, T., Zhou, W., Quinn, D., Glass, D. J., & Klickstein, L. B. (2018). TORC1 inhibition enhances immune function and reduces infections in the elderly. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaq1564

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.